Skip to content

To Study effect of Haritaki Churna in Pain during menstrual cycle (Primary Dysmenorrhoea).

Open Randomized Control Clinical Trial Of Haritaki Churna In The Management Of Udavartini Yonivyapad with Special Reference To Primary Dysmenorrhoea.

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/12/038902
Enrollment
68
Registered
2021-12-24
Start date
Unknown
Completion date
Unknown
Last updated
2022-02-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N944- Primary dysmenorrhea

Interventions

None listed

Sponsors

HonShriAnnasaheb Dange Ayurved Medical CollegeAshta
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients between age group of 15-25yr 2. Patients presenting with pratyatma lakshanas of Udavartini yoni vyapad. 3. Patients suffering for more than 3 consecutive cycle. 4. Ptient with regular menstrual cycle. 5. Patients of Madhym & Krura Koshtha. 6. Patients having a Vataj Prakruti.

Exclusion criteria

Exclusion criteria: Patients with fibroid uterus, malignancy, uterine polyps, cervical polyps, PID, endometriosis, IUCDâ??S etc., diseases related to urogenital system. 2. Patients with systemic disorders like diabetes mellitus, hypertension,tuberculosis etc.,Patient with mrudu koshta. 4. patient having secondary dysmenorrhoea. 5. Lactating mother. 6. Patients on hormonal therapy and OCPâ??s.

Design outcomes

Primary

MeasureTime frame
To evaluate the efficacy of Haritaki Churna in Udavartini Yonivyapad.Timepoint: 7 days before menses for 3 consecutive menstrual cycle

Secondary

MeasureTime frame
To compare the efficacy of Haritaki Churna and Shatapushpa Churna in Udavartini Yonivyapad.Timepoint: 7 days before menses for 3 consecutive menstrual cycle

Countries

India

Contacts

Public Contactvd Shubham Mali

Hon.Shri.Annasaheb Dange Ayurved Medical College, Ashta.

drdilipkatareashta@gmail.com9881215521

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026